- Preamble [SYSTEM]
- Fund & Investor Interest
- Street Moves
- Solebury Trout Updates
- Market Commentary
- IPO News
- Expert Interactions
- Banker Comments & Notes
- Conference Snippet
- Industry Snippets
- Social Media
- Solebury Trout Talks

IPO News: Generation Bio File $125mm IPO
Generation Bio
Generation Bio
NASDAQ: GBIO
Size: $125mm
Bookrunners: J.P. Morgan | Jefferies | Cowen
Major Holders: Atlas Venture Fund | Fidelity | T. Rowe Price | Invus Public Equities
Description: Generation Bio is an innovative genetic medicines company creating a new class of gene therapy utilizing their proprietary non-viral gene therapy platform to provide durable, redosable treatments for millions of patients living with rare and prevalent diseases.
Reference Link: S-1